Document Detail


TSH and prolactin secretions in Hashimoto's thyroiditis following withdrawal of thyroid hormone therapy.
MedLine Citation:
PMID:  6796396     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Changes in the pituitary-thyroid axis in patients with Hashimoto's thyroiditis following withdrawal of thyroid suppressive therapy were analyzed. The group of patients with thyroid adenoma served as control (group I). Patients with Hashimoto's thyroiditis were divided into 2 groups on the basis of serum TSH levels 8 weeks after discontinuing the exogenous thyroid hormone (group II, less than 10 microunits/ml; group III, more than 10 microunits/ml). During treatment with L-T4(200 micrograms/day) or L-T3(50 micrograms/day), there was no significant difference in serum T4-I and T3 levels among the three groups. Following L-T4 withdrawal, basal serum TSH levels were higher at 2 to 8 weeks in groups II and III than in group I. Serum TSH response to TRH was greater at 4 to 8 weeks in groups II and III than in group I. Following L-T3 withdrawal, basal serum TSH levels were higher at 1 and 2 weeks in group II than in group I, while those of group III were consistently higher during the study. Higher TSH responses to TRH were observed at 1 to 8 weeks in groups II and III. Neither basal nor TRH-induced prolactin (PRL) secretion differed significantly among the three groups. We have demonstrated that pituitary TSH secretion in patients with Hashimoto's thyroiditis is affected more by withdrawal of thyroid hormone therapy than in patients with thyroid adenoma. In addition, the present findings suggest a difference between the sensitivity of thyrotrophs and lactotrophs in Hashimoto's thyroiditis after prolonged thyroid therapy is discontinued.
Authors:
N Ohsawa; I Kobayashi; K Suwa; N Kamio; S Maruta; K Ohshima; H Fukuda; S Kobayashi
Related Documents :
7836246 - Thyrotoxicosis--treatment by i131 therapy and early prediction of hypothyroidism follow...
1739056 - Practical approach to the treatment of hypothyroidism.
6372346 - Simple and sensitive method for estimation of antithyroid plasma membrane antibodies in...
2158026 - Physiologic thyroid activation in normal early pregnancy is induced by circulating hcg.
4353776 - Circadian rhythm of plasma aldosterone concentration in patients with primary aldostero...
2923936 - The plasma dexamethasone window: evidence supporting its usefulness to validate dexamet...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Endocrinologia japonica     Volume:  28     ISSN:  0013-7219     ISO Abbreviation:  Endocrinol. Jpn.     Publication Date:  1981 Jun 
Date Detail:
Created Date:  1982-02-12     Completed Date:  1982-02-12     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  0376546     Medline TA:  Endocrinol Jpn     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  329-34     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenoma / drug therapy,  physiopathology
Female
Humans
Prolactin / secretion*
Substance Withdrawal Syndrome / physiopathology
Thyroid Neoplasms / drug therapy,  physiopathology
Thyroiditis, Autoimmune / drug therapy,  physiopathology*
Thyrotropin / secretion*
Thyrotropin-Releasing Hormone / pharmacology
Thyroxine / blood,  therapeutic use
Triiodothyronine / blood,  therapeutic use
Chemical
Reg. No./Substance:
24305-27-9/Thyrotropin-Releasing Hormone; 6893-02-3/Triiodothyronine; 7488-70-2/Thyroxine; 9002-62-4/Prolactin; 9002-71-5/Thyrotropin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of thyrotropin-releasing hormone on rat myometrium.
Next Document:  Seasonal variation in pituitary gonadotropin in the adult male newt, Cynops pyrrhogaster pyrrhogaste...